Sign in
Taking people in United StatesNo phase

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Key facts

Who runs it
The University of Texas at Dallas
Where
Addison, Dallas, and Tallahassee, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
330 people, planned
Started
1 May 2019
Expected to end
1 Jan 2028
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Active rTMS
  • Sham rTMS
  • Cognitive Processing Therapy
Record updated
20 August 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Veterans of Post-9/11 military conflicts
  • with diagnosis of PTSD based on CAPS-5 related to Post-9/11 military combat

Who cannot take part

  • PTSD-inducing trauma exposure occurring within the last 3 months prior to pre-enrollment evaluation
  • previous rTMS
  • history of epilepsy or seizure disorder, a history of major head trauma,
  • any neurologic condition likely to increase risk of seizures,
  • moderate to severe substance use disorder in last 3 months or any substance use that puts the participant at increased risk or significant impairment
  • stroke, and blood vessel abnormalities in the brain,
  • dementia,
  • Parkinson's disease, Huntington's chorea, or multiple sclerosis
  • a lifetime history of psychotic disorder or bipolar disorder
  • inability to stop taking any medication that significantly lowers the seizure threshold
  • We will screen for a history of traumatic brain injury and exclude potential participants from the study if they have a history of severe TBI or are at high risk for seizures
  • history of seizures
  • cardiac pacemaker, implanted medication pumps of any sort that would increase the risk of rTMS
  • any current medical condition that could preclude being able to safely participate in TMS treatment,
  • use of prescription medication or illegal substances that lower the seizure threshold
  • current enrollment in an acute experimental treatment for PTSD or trauma-focused psychotherapy treatment
  • brain tumors,
  • a high suicide risk
  • pregnant or nursing
  • metal fragments in the head, or any metal objects in or near the head that cannot be safely removed
  • non-English speakers because not all of the screening forms, questionnaires, and tests are available in any language except for English

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

This trial is currently available in United States.

  • Metrocare Services of DallasAddison, United StatesContact: Steven A Cohen Military Family Clinic at MetrocareTaking people
  • The University of Texas at DallasDallas, United StatesContact: Celia HigginbothamTaking people
  • Florida State University College of MedicineTallahassee, United StatesContact: FSU NeuromodulationTaking people

About the trial

What the trial wants to find out

The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.

The 3 groups in the trial

  • Sham rTMS + CPTSham treatment, for comparison

    30 minutes of sham repetitive transcranial magnetic stimulation (rTMS) to the right dorsolateral prefrontal cortex (rDLPFC) prior to each Cognitive Processing Therapy (CPT) session

    Treatment: Active rTMS and Cognitive Processing Therapy

  • Active rTMS + CPTExisting treatment, for comparison

    30 minutes of 1 Hz rTMS to rDLPFC prior to each CPT session

    Treatment: Sham rTMS and Cognitive Processing Therapy

  • Active rTMS AloneExisting treatment, for comparison

    30 minutes of 1 Hz rTMS to rDLPFC at 1 session per week over 12 weeks

    Treatment: Active rTMS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT03932773, who can take part
Record updated
20 August 2026